- Home
- IRT vs APLS Comparison
IRT vs APLS Comparison
Compare IRT & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRT
- APLS
- Stock Information
- Founded
- IRT 2009
- APLS 2009
- Country
- IRT United States
- APLS United States
- Employees
- IRT N/A
- APLS N/A
- Industry
- IRT Real Estate Investment Trusts
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- IRT Real Estate
- APLS Health Care
- Exchange
- IRT Nasdaq
- APLS Nasdaq
- Market Cap
- IRT 4.4B
- APLS 4.4B
- IPO Year
- IRT 2013
- APLS 2017
- Fundamental
- Price
- IRT $21.38
- APLS $34.63
- Analyst Decision
- IRT Buy
- APLS Buy
- Analyst Count
- IRT 8
- APLS 19
- Target Price
- IRT $20.00
- APLS $49.89
- AVG Volume (30 Days)
- IRT 2.0M
- APLS 4.1M
- Earning Date
- IRT 10-30-2024
- APLS 11-05-2024
- Dividend Yield
- IRT 2.99%
- APLS N/A
- EPS Growth
- IRT N/A
- APLS N/A
- EPS
- IRT N/A
- APLS N/A
- Revenue
- IRT $641,630,000.00
- APLS $715,216,000.00
- Revenue This Year
- IRT N/A
- APLS $95.53
- Revenue Next Year
- IRT $5.01
- APLS $12.94
- P/E Ratio
- IRT N/A
- APLS N/A
- Revenue Growth
- IRT N/A
- APLS 162.10
- 52 Week Low
- IRT $13.95
- APLS $24.34
- 52 Week High
- IRT $22.26
- APLS $73.80
- Technical
- Relative Strength Index (RSI)
- IRT 57.52
- APLS 66.90
- Support Level
- IRT $20.91
- APLS $33.60
- Resistance Level
- IRT $22.13
- APLS $35.53
- Average True Range (ATR)
- IRT 0.35
- APLS 1.73
- MACD
- IRT -0.00
- APLS 0.80
- Stochastic Oscillator
- IRT 45.71
- APLS 90.79
About IRT Independence Realty Trust Inc.
Independence Realty Trust Inc is a real estate investment trust (REIT) that acquires, owns, operates, improves and manages multifamily apartment communities across non-gateway U.S. markets. It owns and operates multifamily apartment properties, across non-gateway U.S markets, including Louisville, Memphis, Atlanta, and Raleigh. The company is focused on gaining scale within key amenity-rich submarkets that offer school districts, retail, and various employment centers.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.